BSP Pharmaceuticals spa

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40011706

Informations générales

Localisation

Italy

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

14/12/2023

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2031

Statut

Targets set

Classification

1.5°C

Année cible

2031

Progression vers l'objectif69%
2015 (année de référence)2031
Description complète des objectifs

BSP Pharmaceuticals commits to reduce absolute scope 1 and 2 GHG emissions 47% by 2031 from a 2021 base year. BSP Pharmaceuticals also commits to reduce scope 3 GHG emissions from capital goods, fuel and energy related activities and employee commuting 55% per m2 of operated campus within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

8156002794F3EB120038

Source : Science Based Targets initiative | Données publiques